PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

DISEASE CHARACTERISTICS: * Histological confirmation of 1 of the following: * Ovarian epithelial carcinoma * Fallopian tube cancer * Primary peritoneal cancer * Advanced colorectal carcinoma * Other malignancy confined to the peritoneal cavity or peritoneal surfaces * No lesion greater than 2 cm in greatest diameter based on surgical re-assessment * Low burden of tumor in the abdominal or pelvic cavities and no clinically significant ascites * Received potentially effective therapy when available (e.g., platinum/taxane for ovarian cancer, fluoropyrimidine-based therapy for colorectal cancer) * No concurrent hematological malignancy (e.g., chronic lymphocytic leukemia or non-Hodgkin's lymphoma) * No bilateral adrenal metastases * No adrenal metastases in the remaining adrenal gland after adrenalectomy (including radical nephrectomy) * No lung tumors 5 cm or more * No pleural effusions (at least 25% of hemithorax) by radiography * No CNS metastases by CT scan or MRI PATIENT CHARACTERISTICS: Age * 18 and over Performance status * Karnofsky 70-100% Life expectancy * More than 3 months Hematopoietic * WBC at least 3,000/mm\^3 * Absolute neutrophil count at least 1,000/mm\^3 * Platelet count at least 100,000/mm\^3 * Hemoglobin greater than 9 g/dL Hepatic * Bilirubin no greater than 1.5 times upper limit of normal (ULN) * AST and ALT no greater than 1.5 times ULN * Alkaline phosphatase no greater than 1.5 times ULN * No uncontrolled hepatic dysfunction * No active hepatitis B or C Renal * See Disease Characteristics * Creatinine no greater than 1.6 mg/dL AND/OR * Creatinine clearance at least 50 mL/min * No uncontrolled renal dysfunction Cardiovascular * No uncontrolled cardiovascular dysfunction * No myocardial infarction within the past 6 months * No life-threatening arrhythmias within the past 6 months Pulmonary * See Disease Characteristics * No uncontrolled pulmonary dysfunction * No pulmonary atelectasis (lobar) * No pulmonary infiltrates (lobar) * No pulmonary consolidation (lobar or segmental) * No baseline grade II dyspnea Adrenal * See Disease Characteristics * No uncontrolled adrenal dysfunction * No known adrenal insufficiency Other * Not pregnant or nursing * Negative pregnancy test * Fertile patients must use effective contraception * No uncontrolled gastrointestinal dysfunction * No neurological dysfunction * No serious medical or psychological condition that would preclude study participation or increase the risk of adverse effects of the study treatment * No history of serious immunodeficiency * No active uncontrolled bacterial infection (including asymptomatic urinary tract infection) * No contraindication to intraperitoneal therapy including the following: * Intra-abdominal infection * Dense widespread adhesions * Peritonitis * Periumbilical infection * Bowel obstruction * Ileostomy * No hypersensitivity to eggs * No continued contact with live birds (e.g., poultry farmers, veterinarians, laboratory technicians, pet store owners, breeders) PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * See Disease Characteristics * No more than 3 prior cytotoxic chemotherapy regimens * More than 30 days since prior chemotherapy Endocrine therapy * More than 14 days since prior systemic corticosteroids Radiotherapy * More than 30 days since prior radiotherapy Surgery * See Disease Characteristics * No prior complete or partial lobectomy with removal of lung tissue at least segmental size * No prior organ allograft Other * Recovered from prior therapy * More than 14 days since prior antiviral medication * More than 4 weeks since prior immunosuppressive drugs * No other concurrent investigational drugs * No concurrent chronic immunosuppressive drugs (e.g., cyclosporine) * No vaccination for influenza within 48 hours of study drug administration * No concurrent hypoglycemic agents * No concurrent antiretroviral therapy for HIV-positive patients * No other concurrent anticancer therapy